CONCLUSION
With the increase of extended-spectrum antimicrobial application, AB is rapidly evolving toward multidrug resistance. In our study multidrug resistance AB rate was high. Nosocomial infections caused by AB are very difficult to treat. AB infections are associated with high high morbidity and mortality rate.Knowing the risk factors that indicate mortality in such patients and ensuring early diagnosis are of critical importance with respect to prognosis. Starting appropriate therapy by making the right decisions regarding the severity of acute and underlying conditions will have favorable effects on the management of A. baumannii bacteremia.
In conclusion, the risk factors that indicate mortality in patients and these patients are closely watched and bacterial early determination of the importance of the prognosis of the patient bears. Severe acute illness and underlying disease start appropriate treatment by making the right decision, the effect will be better in the A. baumannii bacteria. Also avoid unnecessary antibiotic treatment and prophylaxis and can be controlled as strict infection control measures abolition of risk factors, originating from A. Baumannii reduce possible bactericides and related deaths.
REFERENCES
1. Del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D, Molina F, Villanueva R, Cisneros JM, Bou G. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk factors for colonisation and infection. Clin Microbiol Infect 2005;11: 540-546.
2. Dettori M, Piana A, Deriu MG, Lo Curto P, Cossu A, Musumeci R, Cocuzza C, Astone V, Contu MA, Sotgiu G . Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit. New Microbiol 2014; 37: 185- 191.
3. Ye D, Shan J, Huang Y, Li J, Li C, Liu X, He W, Li Y, Mao P. A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China. BMC Infect Dis.2015; 15: 179.
4. Dalla-Costa LM, Coelho JM, Souza HA, Castro ME, Stier CJ, Bragagnolo KL, Rea-Neto A, Penteado-Filho SR, Livermore DM, Woodford N . Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003;41: 3403-3406.
5. Teo J, Lim TP, Hsu LY, Tan TY, Sasikala S, Hon PY, Kwa AL, Apisarnthanarak A .Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations. Antimicrob Resist Infect Control 2015;4:2.
6. Markogiannakis A, Fildisis G, Tsiplakou S, Ikonomidis A, Koutsoukou A, Pournaras S, Manolis EN, Baltopoulos G, Tsakris A .Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect Control Hosp Epidemiol 2008;29: 410-417.
7. Senok A, Garaween G, Raji A, Khubnani H, Kim Sing G, Shibl A . Genetic relatedness of clinical and environmental Acinetobacter baumanii isolates from an intensive care unit outbreak. J Infect Dev Ctries 2015;9: 665-669.
8. Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, Jarlier V, Voss A, Pittet D. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control. 2013;2:2-31.
9. Samuel S, Kayode O, Musa O, Nwigwe G, Aboderin A, Salami T, Taiwo S. Nosocomial infections and the challenges of control in developing countries. Afr J Clin Exp Microbiol. 2010;11:102-9.
10. Hasanin A, Eladawy A, Mohamed H, Salah Y, Lotfy A, Mostafa H, Ghaith D, Mukhtar A. Prevalence of extensively drug-resistant gram negative bacilli in surgical intensive care in Egypt. Pan Afr Med J. 2014;19:177,4307.
11. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant A. baumannii. Br Soc Antimicrob Chemother. 2010;428.
12. Chang YJ, Yeh ML, Li YC, Hsu CY, Lin CC, Hsu M-S, Chiu WT. Predicting hospital-acquired infections by scoring system with simple parameters. PLoS One. 2011;6:1-11.
13. Simonetti AF, Viasus D, Garcia-Vidal C, Carratalà J. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014;2:3-16.
14. Hill R, Paulus S, Dey P, Hurley MA, Carter B. Is undernutrition prognostic of infection complications in children undergoing surgery? A systematic review. J Hosp Infect. 2016;93:12-21.
15. Gyansa-Lutterodt M, Afriyie D, Asare G, Amponsah S, Abutiate H, Darko D. Antimicrobial use and susceptibility pattern of uropathogens associated with urinary tract infections at the Ghana Police Hospital. Glob J Pharmacol. 2014;8:306-15
16. Ghaith DM, Hassan RM, Hasanin AM. Rapid identifcation of nosocomial A. baumannii isolated from a surgical intensive care unit in Egypt. Ann Saudi Med. 2015;36(5):440-4.
17. Hasanin A, Mukhtar A, El-Adawy A, Elazizi H, Lotfyn A, Nassar H, Ghaith D. Ventilator associated pneumonia caused by extensive-drug resistant Acinetobacter species: colistin is the remaining choice. Egypt J Anaesth. 2016; 3-4
18. Lee HY, Chen CL, Wu SR, Huang CW, Chiu CH. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med 2014;42:1081-1088.
19. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006; 64:7-15.
20. Zhou HY, Yuan Z, Du YP. Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis. Int J Infect Dis 2014;22:25-30.
21. Katsaragakis S, Markogiannakis H, Samara E, et al. predictors of mortality of Acinetobacter baumannii infections: A 2-year prospective study in a Greek surgical intensive care unit. Am J Infect Control 2010; 38: 631-5.
22. Prates CG, Martıns AF,Supertı SV, Lopes FS, Ramos F, Cantarellı VV, et al. Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit. Epidemiol Infect 2011;139:411-8
23. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995;74:340-9.
24. Cisneros JM, Reyes MJ, Pacho´n J, Becerril B, Caballero FJ, Garcı´aGarmendı´a JL, et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996; 22:1026-32.
25. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995; 20:790-6.
25. Go´mez J, Simarro E, Ban˜os V, Requena L, Ruiz J, Garcı´a F, et al. Sixyear prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1999; 18: 358-61.
27. Cisneros JM, Rodriguez-Ban˜o J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687-93.
28. Reina R, Estenssoro E, Sa´enz G, Canales HS, Gonzalvo R, Vidal G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 2005; 31: 1058-65.
29. Chen HP, Chen TL, Lai CH, Fung CP, Wong WW, Yu KW, et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005;38:127-36.
30. del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D, et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk factors for colonisation and infection. Clin Microbiol Infect 2005;11:540-6.
31. Choi JY, Park YS, Kim CO, Park YS, Yoon HJ, Shin SY, et al. Mortality risk factors of Acinetobacter baumannii bacteraemia. Intern Med J 2005; 35:599-603.
32. Garnacho-Montero J, Ortiz-Leyba C, Ferna´ndez-Hinojosa E, Aldabo´- Palla´s T, Cayuela A, Marquez-Va´caro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005; 31:649-55.
33. Kaul R, Burt JA, Cork L, Dedier H, Garcia M, Kennedy C, et al. Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: risk factors and attributable mortality. J Infect Dis 1996; 174:1279-87.
34. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005; 11:115-21.
25. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000; 28:1871-6.